Document Detail


A Multicenter Phase II Trial to Determine the Safety and Efficacy of Combination Therapy With Denileukin Diftitox and CHOP in Untreated Peripheral T-Cell Lymphoma: The CONCEPT Study.
MedLine Citation:
PMID:  23278639     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
ABSTRACT This phase II study to determine the safety and efficacy of denileukin diftitox (DD) and CHOP enrolled patients with newly diagnosed peripheral T-cell lymphoma (PTCL). Forty-nine received DD 18 µg/kg/day (days 1, 2) with CHOP (day 3) every 21 days ≤6-8 cycles. Intent-to-treat (ITT) and safety populations comprised all patients. In the ITT population, overall response rate was 65%, median duration of response was 30 months, and median progression-free survival was 12 months. Median overall survival was not attained at the end of the study, and overall survival rate was 63.3%. The 2 most frequent treatment-related adverse events (AEs) were fatigue and nausea. Most frequent AEs ≥grade 3 within the hematologic system were lymphopenia (24.5%), neutropenia (20.4%), and leukopenia (18.4%). Three treatment-related deaths occurred. DD plus CHOP was well tolerated, and progression-free and overall survival improved versus historical comparison with CHOP alone. Confirmation in larger trials is warranted. ClinicalTrials.gov Identifier: NCT00211185.
Authors:
Francine M Foss; Nelida Sjak-Shie; Andre Goy; Eric Jacobsen; Ranjana Advani; Mitchell R Smith; Rami Komrokji; Kelly Pendergrass; Vanessa Bolejack
Related Documents :
10624349 - Ct guided interstitial high dose rate brachytherapy for recurrent malignant gliomas.
8083099 - Evaluation of external beam therapy and three brachytherapy fractions for carcinoma of ...
12558559 - Palliative treatment of unresectable bile duct tumours.
8638529 - Management of stage i-b, ii-a, and ii-b carcinoma of the cervix with high-dose-rate bra...
20045789 - Vesical instillations of hyaluronic acid to reduce the acute vesical toxicity caused by...
22613459 - Case report: lymphoepithelial-like carcinoma of the lung--a chronic disease?
1593679 - Localized urethral tumors in women: indications for conservative versus exenterative th...
11023499 - Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.
8729619 - In vitro uptake of bromodeoxyuridine by human nasopharyngeal carcinoma (npc) and its re...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-2
Journal Detail:
Title:  Leukemia & lymphoma     Volume:  -     ISSN:  1029-2403     ISO Abbreviation:  Leuk. Lymphoma     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9007422     Medline TA:  Leuk Lymphoma     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Characteristics of 244 patients with keratoconus seen in an optometric contact lens practice.
Next Document:  Pharmacologic prophylaxis regimens for acute graft-versus-host disease: past, present and future.